Brief
For U.S. Life Sciences Real Estate, 2026 Is a Tale of Stabilization
The U.S. life sciences real estate market remains oversupplied, but improving funding conditions and a sharply reduced construction pipeline are beginning to set the stage for a recovery, according to
The U.S. life sciences real estate market remains oversupplied, but improving funding conditions and a sharply reduced construction pipeline are beginning to set the stage for a recovery, according to Cushman & Wakefield. Asking rents at U.S. life sciences facilities averaged $64.17 per square foot in the second quarter of 2026, down 5.3 percent compared […]
Source
- Commercial Observercommercialobserver.com
